Keyphrases
Genome Analysis
83%
Single-cell DNA Sequencing
83%
Cancer Types
83%
Ubiquitination Pathway
83%
Breast Cancer
83%
Pathways in Cancer
33%
Tumor
33%
Sequence Method
33%
Tumor Samples
33%
Cancer Development
33%
In Cancer
33%
Ubiquitin
33%
Development Products
27%
Definitive Endoderm Differentiation
27%
DNA Repair Pathways
16%
Cancer Patients
16%
BRAF mutation
16%
Poor Survival
16%
Exome Sequencing
16%
High-throughput
16%
Reversible Process
16%
Cancer Cells
16%
Profile Information
16%
Type-specific
16%
FBXW7
16%
Comprehensive Characterization
16%
Microfluidic Platform
16%
Pathway Genes
16%
Multiple Omics Data
16%
TP53 mutation
16%
Targeted Panel
16%
Genomic Regions
16%
Copy number
16%
Dynamic Process
16%
Tumor Protein p53 (TP53)
16%
Mutation Sites
16%
Pan-cancer
16%
Somatic mutation
16%
Mutually Exclusive
16%
Triple-negative Breast Cancer
16%
Molecular Characterization
16%
Specific Pattern
16%
Omics Data
16%
Technical Obstacles
16%
Worse Prognosis
16%
Protein Ubiquitination
16%
Ubiquitin Chains
16%
Tumor Evolution
16%
Cancer Genome Atlas
16%
Murine Double Minute 2 (MDM2)
16%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Cell Survival
83%
Ubiquitin
83%
Stem Cell
83%
Sirtuin
83%
Endoderm
83%
DNA Sequence
83%
Cell Function
83%
Insulin Release
31%
Cellular Differentiation
31%
Histone H3
31%
Acetylation
20%
Thioredoxin
20%
Upregulation
20%
RNA Polymerase II
20%
Precursor
20%
Lysine
20%
Progenitor Cell
20%
Streptozotocin
20%
Gene Expression
20%
Cancer Cell
16%
Somatic Mutation
16%
Exome Sequencing
16%
Ubiquitination
10%
Promoter Region
10%
Cell Viability
10%
Immunoblotting
10%
RNA Sequencing
10%
Tamsulosin
10%
FBXW7
10%
DNA Repair
10%
Knockout Mouse
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Histone Deacetylase
10%
Chromatin Immunoprecipitation
10%
Deacetylation
10%
Genetics
10%
Homeostasis
10%
Pan-cancer
10%
Cell Cycle
10%
Epigenetics
10%
Cell Maturation
10%
Medicine and Dentistry
Breast Cancer
83%
Sirtuin 6
83%
Endoderm
83%
Pluripotent Stem Cell
83%
DNA Sequence
83%
Cell DNA
83%
Neoplasm
50%
Precursor
27%
Lung
27%
Medicine
27%
In Vitro
27%
Combination Therapy
27%
Pluripotent Stem Cell Differentiation
27%
Somatic Mutation
16%
Exome Sequencing
16%
Cancer Cell
16%
Triple Negative Breast Cancer
16%
Malignant Neoplasm
16%
